Inverness Medical Innovations Acquires Rapid Diagnostics Business of ACON Laboratories for UK Market - To Operate as Innovacon, Inc.

The acquired business will operate going forward under the nameInnovacon, Inc., which is a wholly-owned subsidiary of InvernessMedical Innovations.

Inverness' acquisition of the ACON business was negotiated afterACON and its most significant distributor of women's health productsadmitted infringement of one of Inverness' UK patents covering itsproprietary immunoassay technology and the distributor agreed to bebound by a permanent injunction issued by the High Court of Justice,Chancery Division, from importing and selling ACON pregnancy andovulation tests.

Inverness Medical Innovations is a leading global developer ofadvanced diagnostic devices and is presently exploring newopportunities for its proprietary electrochemical and othertechnologies in a variety of professional diagnostic andconsumer-oriented applications including immuno-diagnostics with afocus on women's health, cardiology and infectious disease. TheCompany's new product development efforts, as well as its position asa leading supplier of consumer pregnancy and fertility/ovulation testsand rapid point-of-care diagnostics, are supported by the strength ofits intellectual property portfolio. Inverness is headquartered inWaltham, Massachusetts.

For more information about Inverness Medical Innovations, pleasevisit our website at http://www.invernessmedical.com.

Innovacon Inc., a wholly-owned subsidiary of Inverness MedicalInnovations, is a leading provider of Drugs of Abuse, Fertility,Infectious Diseases, and Cardiac/Tumor Marker lateral flow diagnostictests in a choice of easy-to-use formats, to markets in the UnitedStates, Canada, Western Europe, Japan, Australia, Israel, and NewZealand. Innovacon is committed to providing its customers with highquality competitively priced custom-designed rapid diagnostics.